Strategic Partnering to Evaluate Cancer Signatures SPECS II U01 Federal Grant

Home

RESEARCH

ARTICLES

RESOURCES

Government Jobs
Grant Forums

FAST GRANT SEARCH

FEDERAL GRANTS NEWSLETTER

Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01)

The summary for the Strategic Partnering to Evaluate Cancer Signatures [SPECS II] (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.

Federal Grant Title:	STRATEGIC PARTNERING TO EVALUATE CANCER SIGNATURES [SPECS II] (U01)
Federal Agency Name:	National Institutes of Health
Program Name:	Cancer Detection and Diagnosis Research
Grant Categories:	Education Health
CFDA Number:	93.394
Funding Opportunity Number:	PAR-11-151
Posted Date:	Mar 14, 2011
Creation Date:	Mar 14, 2011
Original Application Deadline:	Jun 15, 2012
Current Application Deadline:	Jun 15, 2012
Archive Date:	Jul 16, 2012
Total Program Funding:	Information not provided
Maximum Federal Grant Award:	$680,000
Minimum Federal Grant Award:	Information not provided
Expected Number of Awards:	Information not provided
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: State governments - Public and State controlled institutions of higher education - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components on applications submitted by U.S. Organizations are allowed.
Grant Description: This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), encourages the submission of grant applications for support of the clinical application of multi-analyte molecular signatures derived from comprehensive molecular annotation of tumors. There is growing recognition in the clinical cancer research community that annotation of tumor specimens with data that integrates information about molecular alterations at the levels of DNA, RNA, and protein provides not only a more complete understanding of tumor biology but also provides a significant opportunity for developing new clinical tools to improve cancer treatment. Translating the knowledge gained from this molecular annotation into tools that can be used in clinical decision-making remains a major challenge. The purpose of this initiative is to build on recent demonstrations that molecular signatures correlate with important clinical parameters in cancer. The goal of this initiative is also to create publications and data sets that will be available and accessible to the scientific community in order to further the development, design, and conduct of future clinical trials (e.g., incorporation of molecular signatures into future clinical trials and large clinical validation studies) and to encourage appropriate commercialization to benefit the public health. The NCI invites investigators to form strategic partnerships that will bring together the multi-disciplinary expertise and resources needed to determine how the information derived from comprehensive molecular analyses can be used to improve patient care and, ultimately, patient outcomes.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/par-11-151.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Revisions to P50 Awards for Research on Detection of Pathogen-Induced Cancer (DPIC) (P50); • Revisions to P01 Awards for Research on Detection of Pathogen-Induced Cancer (DPIC) (P01); • Revision Applications to U01 Awards on Detection of Pathogen-Induced Cancer (DPIC) (U01); • Revision Applications to R01 Awards for Research on Detection of Pathogen-Induced Cancer (...; • Revision Applications to R01 Awards for Research on Imaging and Biomarkers for Early Cance...; • Image-Guided Cancer Interventions (STTR [R41/R42]); • An SBIR Initiative for Image-Guided Cancer Interventions (R43/R44); • In Vivo Cancer Imaging Exploratory/Developmental Grants
More Grants from the National Institutes of Health: • Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral...; • Research on the Role of Epigenetics in Social, Behavioral, Environmental and Biological Re...; • Pediatric Critical Care and Trauma Scientist Development Program (K12); • Evidence-based Demonstration Projects in Immunization (Admin Supp); • Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the...